New research demonstrates that implementing ET-GBD for cholecystitis significantly improves patient safety during the pre-surgical interval. In patients diagnosed with both acute cholecystitis and choledocholithiasis, clinicians typically perform an ERCP first. However, a significant gap often occurs before the definitive interval cholecystectomy. This waiting period frequently results in recurrent biliopancreatic events, ranging from 18.3% to over 41%. Traditionally, doctors reserved Endoscopic Transpapillary Gallbladder Drainage (ET-GBD) for patients with high surgical risks. This study confirms that even surgically fit patients benefit immensely from this preventative drainage.

The retrospective study analyzed 121 patients between 2018 and 2023. Researchers compared a group receiving ET-GBD against a control group without drainage. Specifically, the waiting period for surgery spanned six weeks to three months. The results were striking and showed a massive difference in complication rates. Only 2.9% of the ET-GBD group experienced events, while 52.9% of the control group suffered complications. This represents an absolute risk reduction of 50%. Consequently, the procedure proved to be a highly effective bridge to surgery.

The Clinical Impact of ET-GBD for Cholecystitis

Performing gallbladder drainage during the initial ERCP provides several clinical advantages. It prevents emergency readmissions and reduces the severity of secondary gallbladder inflammation. Furthermore, the study noted zero procedure-related complications in the drainage group. This high safety profile makes it an attractive option for routine practice. Patients can wait for their scheduled surgery with much greater peace of mind. Additionally, avoiding acute events simplifies the eventual laparoscopic procedure for surgeons.

In conclusion, incorporating ET-GBD into standard ERCP protocols for these patients is highly beneficial. It effectively eliminates the high risk of interval biliary complications. Therefore, gastroenterologists should consider this technique even in patients without significant comorbidities. Future guidelines may soon reflect these findings to enhance preoperative management strategies.

Frequently Asked Questions

How does ET-GBD for cholecystitis prevent future events?

ET-GBD provides continuous drainage of the gallbladder. This prevents the stasis and infection that typically lead to recurrent cholecystitis or biliary colic during the waiting period.

Is ET-GBD safe for patients without comorbid diseases?

Yes, the study specifically showed that even patients without comorbidities experienced significantly fewer complications with no reported side effects from the procedure itself.

Does this drainage affect the final surgery?

By preventing acute inflammatory episodes during the waiting period, ET-GBD may actually make the subsequent interval cholecystectomy safer and more straightforward for the surgeon.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Parlar YE et al. Endoscopic Transpapillary Gallbladder Drainage Reduces The Frequency of Biliopancreatic Events In The Waiting Period For Surgery, Even In Patients Without Comorbid Diseases. Digestion. 2026 Feb 26. doi: 10.1159/000551128. PMID: 41746868.

Kim TH et al. Endoscopic transpapillary gallbladder drainage for the management of acute calculus cholecystitis patients unfit for urgent cholecystectomy. PLoS One. 2020;15(10):e0240388.

Park JK, et al. Recent advances in endoscopic gallbladder drainage. Clin Endosc. 2021;54(1):15-22.